Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence
Top Cited Papers
Open Access
- 16 July 2003
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 424 (6948), 516-523
- https://doi.org/10.1038/nature01850
Abstract
Swift elimination of undesirable cells is an important feature in tumour suppression and immunity. The tumour suppressor p53 and interferon-α and -β (IFN-α/β) are essential for the induction of apoptosis in cancerous cells and in antiviral immune responses, respectively, but little is known about their interrelationship. Here we show that transcription of the p53 gene is induced by IFN-α/β, accompanied by an increase in p53 protein level. IFN-α/β signalling itself does not activate p53; rather, it contributes to boosting p53 responses to stress signals. We show examples in which p53 gene induction by IFN-α/β contributes to tumour suppression. Furthermore, we show that p53 is activated in virally infected cells to evoke an apoptotic response and that p53 is critical for antiviral defence of the host. Our study reveals a hitherto unrecognized link between p53 and IFN-α/β in tumour suppression and antiviral immunity, which may have therapeutic implications.Keywords
This publication has 40 references indexed in Scilit:
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Control of interferon signaling in human papillomavirus infectionCytokine & Growth Factor Reviews, 2001
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- p53 and tumour viruses: Catching the guardian off-guardTrends in Microbiology, 1997
- Interferons and the tumor cellBiotherapy, 1996
- p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell linesCarcinogenesis: Integrative Cancer Research, 1993